Searched for
SYNGENE INTERNATIONAL IPO
Syngene International makes stellar debut, ends day up 24% over issue priceIt hit an intraday high of Rs 318.20 over its issue price, before settling the day at Rs 310.40, up 24.16 per cent on the BSE.11 Aug, 2015, 04.35 PM IST- Alkem Lab approaches SEBI to raise Rs 1,500-3,500 crore via IPOAlkem Laboratories filed draft papers with capital markets regulator Sebi to raise an estimated Rs 1,500-3,500 crore through an IPO.06 Aug, 2015, 09.42 PM IST
- Alkem Laboratories to raise Rs 1,500-3,500 crore via IPO"Alkem will soon file its draft paper with capital market regulator Securities and Exchange Board of India (Sebi) to float an IPO," sources...02 Aug, 2015, 01.08 PM IST
- First pharma IPO in 5 years: Syngene’s debut offer subscribed 32 timesThe Rs 550-crore initial public offer of Syngene, a research arm of Biocon, was subscribed 32 times on the final day of the offer31 Jul, 2015, 12.30 PM IST
- Syngene IPO gets robust response; issue subscribed 32 timesThe Rs 550 crore IPO of Syngene International was over-subscribed 32.03 times on the last day of the offer today as both retail and institu...29 Jul, 2015, 10.09 PM IST
- Syngene IPO over-subscribed on second dayThe IPO got bids for 1,60,79,700 shares against 1,60,00,000 shares on offer, resulting in a subscription of 1.01 (rpt) 1.01 times, accordin...28 Jul, 2015, 09.53 PM IST
- Syngene IPO subscribed 32% on Day 1The initial public offering of biotechnology major Biocon's research arm Syngene International was subscribed 32 per cent on the first day ...27 Jul, 2015, 10.39 PM IST
- Top brokers recommend 'subscribe' to Syngene International IPO; here's whyLong-term investors should 'subscribe' to Syngene IPO which opens for subscription today, various brokerages said in a report.27 Jul, 2015, 10.23 AM IST
- GEPL Capital recommends 'subscribe' to Syngene International IPOSyngene International Ltd, a subsidiary of leading pharma major Biocon Ltd and India’s leading CRO, is planning to raise Rs 550 crore from ...26 Jul, 2015, 12.16 PM IST
- Top five reasons why long-term investors should 'subscribe' to Syngene IPOSyngene is well positioned to capitalize on the advantages of its flexible business models that customize to their clients’ requirements gl...26 Jul, 2015, 12.12 PM IST
- Biocon sets Syngene IPO price band at Rs 240-250Biocon plans to raise Rs 550 crore by diluting 11% stake in Syngene through the Initial Public Offer. The proceeds will mostly go into fund...17 Jul, 2015, 08.27 PM IST
- Syngene IPO opens July 27; price band at Rs 240-250; Biocon shares end in redBiocon's subsidiary Syngene has set the price band for its forthcoming IPO at Rs 240-250 per share that will open on July 27.16 Jul, 2015, 05.22 PM IST
- Syngene IPO money to fund Biocon research: ShawShaw said that Biocon has the largest biosimilar pipeline globally in phase three clinical trials and the IPO will help fund those costs.27 Jun, 2015, 01.09 PM IST
- Plan to list Syngene in August, use IPO proceeds for R&D: Kiran Mazumdar-ShawSyngene International, present in the contract services business, had filed its draft red herring prospectus (DRHP) with Sebi .24 Jun, 2015, 01.07 PM IST
- Syngene gets FIPB nod to raise foreign investment to 44%Syngene, a subsidiary of Biocon, said it has received the Foreign Investment Promotion Board approval to raise foreign investment to 44 per...22 Jun, 2015, 05.56 PM IST
- Biocon's arm Syngene International gets Sebi approval for IPOThe company plans to sell 22 mn equity shares, including reservation of up to two mn shares for Biocon shareholders.15 Jun, 2015, 09.19 PM IST
- Biocon rallies on plans to list unit Syngene InternationalBiocon gained 2% in intraday trade following reports that the co plans to list its research services business arm Syngene International.01 Apr, 2015, 09.35 AM IST
Load More
